Olpha AS

Cardiac rhythm disorders

Olpha AS is active in clinical research focused on atrial fibrillation, with interest in treatments aimed at maintaining sinus rhythm and supporting rhythm control in patients with irregular heart rhythms.

  • Atrial fibrillation
  • Sinus rhythm maintenance
  • Antiarrhythmic therapy

The sponsor’s research activity reflects a therapeutic focus on cardiovascular medicine, particularly the management of rhythm disturbances using established antiarrhythmic agents.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Comparison of Etacizine and Propafenone for maintaining normal heart rhythm in patients with atrial fibrillation

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Latvia